Results 61 to 70 of about 67,047,750 (221)
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Evidence regarding the risk‐stratified effectiveness of drug‐coated balloon (DCB)‐based PCI for de novo coronary artery disease (CAD) remains limited, particularly in patients undergoing complex and high‐risk indicated percutaneous coronary intervention (CHIP PCI).
Dong Oh Kang +3 more
wiley +1 more source
ESC Heart Failure, 2021 Aims Reverse remodelling (RR) is the recovery from left ventricular (LV) dilatation and dysfunction. Many arbitrary criteria for RR have been proposed. We searched the criteria with the strongest prognostic yield for the hard endpoint of cardiovascular ...
Alberto Aimo +16 more
doaj +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Hypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA).
Vojko V. Misevic +12 more
wiley +1 more source
Biomarker profiles of acute heart failure patients with a mid-range ejection Fraction
, 2017 Objectives In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a reduced ...
Khan, MAF +16 more
core +1 more source
Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source
Российский кардиологический журнал, 2021 The problems of heart failure (HF) are becoming increasingly important every year due to the increasing spread of cardiovascular diseases resulting in its development, as well as the impact of metabolic factors, obesity, drugs and endocrine dysfunctions ...
O. V. Tsygankova, V. V. Veretyuk
doaj +1 more source
Heart Failure With Mid-Range (Borderline) Ejection Fraction [PDF]
, 2017 Heart failure (HF) with borderline ejection fraction was first defined in 2013 in the American College of Cardiology/American Heart Association guidelines as the presence of the typical symptoms of HF and a left ventricular ejection fraction (LVEF) of 41%
Fonarow, Gregg C +5 more
core +1 more source
Interventional Mitral Valve Edge‐to‐Edge Repair in Patients Above 85 Years of Age
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Mitral valve transcatheter‐edge‐to‐edge repair (M‐TEER) is routinely performed in patients with severe mitral regurgitation (MR) at high operative risk, frequently including elderly patients. Patients ≥ 85 years, however, are frequently excluded in clinical studies.
Florian Jürgens +8 more
wiley +1 more source
Heart failure with mid-range ejection fraction: Two overlapping entities?
CorSalud, 2019 Heart failure with mid-range ejection fraction: Two overlapping entities?
F. Javier Martín-Sánchez +3 more
doaj
, 2020 BACKGROUND: To examine the influence of heart failure (HF) with preserved ejection fraction (HFPEF) and HF with mid-range ejection fraction (HFmrEF) on perioperative cardiac and noncardiac outcomes following hip fracture ...
Acan, Ahmet Emrah +4 more
core +1 more source